Pixelgen raises $15.5 million Series B for international expansion
Flat Capital led the financing as Pixelgen expands commercial access to its Proxiome Kit and analysis software.
Pixelgen Technologies closed a $15.5 million Series B on August 20, 2026. Flat Capital led the round, with existing investors Industrifonden and Navigare Ventures participating. The Stockholm company will use the financing to expand commercial operations internationally, grow its team and develop its product portfolio.
Its Proxiome Kit maps protein organisation on individual cell surfaces. The company pairs the assay with analysis and visualisation software for life-sciences researchers. Alongside the financing, Flat Capital CEO Rickard El Tarzi and life-sciences technology executive Ramon Felciano joined the board.